Jiangsu HengRui Medicine Co: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies71 active (42 recruiting now)
Total Tracked Studies (2018 to 2026)232 (5 with California sites)
Completed vs Early-Stopped Studies77 completed / 24 stopped (10.3% stop rate)
Median Closed Enrollment187 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk